Fatal brake failures: Tumorigenesis in the colon

by Ludwig Maximilian University of MunichMir34a/p53-deficient metastatic colon cancer cells invading into a lymph node. Brown staining detects high levels of nuclear beta-catenin protein, which i

Updated on: March 08,2024

Fatal brake failures: Tumorigenesis in the colon

by Ludwig Maximilian University of MunichMir34a/p53-deficient metastatic colon cancer cells invading into a lymph node. Brown staining detects high levels of nuclear beta-catenin protein, which i

Updated on:March 08,2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on: July 05,2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on:July 05,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on: January 16,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on:January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on: May 05,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on:May 05,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on: April 07,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on:April 07,2024

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on: January 03,2024

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on:January 03,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on: August 03,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on:August 03,2024

Important to be open to discussing sex with young cancer survivors

by University of GothenburgCredit: University of GothenburgFeeling unattractive and dissatisfied with their sexual ability – that is reality for many teenage and young adult cancer survivors. Res

Updated on: March 01,2024

Important to be open to discussing sex with young cancer survivors

by University of GothenburgCredit: University of GothenburgFeeling unattractive and dissatisfied with their sexual ability – that is reality for many teenage and young adult cancer survivors. Res

Updated on:March 01,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on: September 07,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on:September 07,2024